Dialysis Market

Dialysis Market Size and Share:

The global dialysis market size was valued at USD 120.85 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 180.42 Billion by 2033, exhibiting a CAGR of 4.09% during 2025-2033. North America currently dominates the market in 2024, accounting to 41.0% of the market share. The major drivers of the market include the increasing prevalence of chronic kidney disease and end-stage renal disease, rising diabetes and hypertension cases, technological advancements in dialysis equipment, growing healthcare spending, expanding home dialysis solutions, favorable government policies, reimbursement initiatives, and an aging global population.

The global market is majorly driven by the increasing prevalence of chronic kidney disease and end-stage renal disease. As per industry reports, the proportion of individuals aged 65 years or older is projected to increase from 10% in 2024 to over 16% by 2050. If trends from 1990 to 2016 continue, the prevalence of CKD in categories G3–G5 will likely exceed 10% in many regions by 2050, mainly due to rising rates of diabetes and hypertension, which are key risk factors for kidney disorders. This increase in geriatric population, along with increased healthcare spend in developed and developing economies is providing a boost to the market growth. Additionally, ongoing technological advancements in dialysis equipment and procedures and awareness about renal health is propelling the market. Apart from this, favorable government initiatives, reimbursement policies, and availability of home dialysis solutions are stimulating the market appeal.

The United States stands out as a key regional market, and is primarily driven by the growing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), mainly due to increasing cases of diabetes and hypertension. In line with this, growing demographics with a higher inclination towards age-related kidney issues is increasing the demand further. Furthermore, ongoing technological advancements in dialysis machines, such as improved filtration methods, better biocompatibility of materials, more precise monitoring systems, and automation for personalized treatment, and telehealth integration is making the process more convenient for patients, thereby supporting the market. For instance, on December 6, 2024, Fresenius announced plans for a broad U.S. commercial launch of hemodiafiltration (HDF) technology in 2025, emphasizing its potential to improve patient outcomes through increased convective clearance and reduced hospitalizations. During Kidney Week 2024, Fresenius highlighted its 5008X dialysis machine, which enables outpatient HDF without significant water system retrofitting, and showcased studies demonstrating HDF's benefits in mortality, anemia, and quality of life compared to standard hemodialysis. Besides this, favorable reimbursement policies by Medicare and Medicaid significantly support accessibility to treatment. Moreover, the presence of major dialysis service providers, is contributing to the expansion of the dialysis market in the U.S.

Dialysis Market Trends:

Increasing lifestyle changes lead to kidney complications

The escalating trend of lifestyle changes is stimulating the market.. According to National Institutes of Health, chronic kidney disease (CKD) affects over 1 in 7 U.S. adults, impacting an estimated 35.5 million Americans, highlighting a growing public health concern. Unhealthy diets rich in processed foods, high salt content, and inadequate hydration can lead to chronic conditions such as hypertension and diabetes, which are major causes of kidney diseases. The correlation between lifestyle factors and kidney complications has prompted an upswing in the prevalence of chronic kidney diseases. This rise in kidney-related issues subsequently increased the demand for dialysis treatments, as affected individuals require renal replacement therapy to maintain their quality of life. The expanding patient pool necessitates the expansion of dialysis services, further propelling the market. Apart from this, ongoing innovations by healthcare providers, medical device manufacturers, and researchers to develop solutions and strategies to address this growing demand and offer effective dialysis interventions, is fostering the market further.

Expansion of private dialysis clinics and centers

The rise in the number of private dialysis clinics and centers that offer several key advantages contribute to the impact on market expansion. According to National Library of Medicine, India has nearly 950 nephrologists and over 700 dialysis centers with 4,000 machines, predominantly in the private sector, largely concentrated in metros. The growing demand for dialysis is driving the expansion of private facilities across the country. Private clinics often provide specialized and personalized care tailored to the unique needs of individual patients. This level of customization improves patient satisfaction and outcomes, attracting a larger clientele and strengthening the market demand. Furthermore, private dialysis centers tend to offer more flexible scheduling options, accommodating patients' preferences and routines. This convenience factor attracts individuals seeking treatments that align with their busy lifestyles. Moreover, the establishment of private clinics fosters healthy competition within the market. This competition encourages innovation in treatment methodologies, technology adoption, and patient services, ultimately leading to improved quality of care across the industry. Additionally, private facilities are often well-equipped with the latest dialysis machines, technologies, and skilled medical personnel, ensuring efficient and effective treatments. This high standard of care helps build trust among patients and referring physicians, further driving patient referrals and market growth. Private dialysis clinics contribute to reducing the burden on public healthcare systems by providing alternative options for patients seeking dialysis services. This aspect is particularly crucial in regions with limited public resources, as private centers can alleviate strain on the healthcare infrastructure.

Rising demand for Improved Peritoneal Dialysis Techniques

The escalating demand for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) is fueling the market growth. According to reports, nocturnal automated peritoneal dialysis (APD) usage rising in the United States, now comprises 86% of patients on incident peritoneal dialysis (PD), reflecting a significant shift towards more advanced treatment options. These advanced peritoneal dialysis techniques offer numerous advantages that contribute to their increasing popularity. CAPD and APD provide patients with more flexible and convenient treatment options than traditional in-center hemodialysis. CAPD allows patients to perform manual exchanges of dialysate fluid throughout the day, offering greater freedom and the ability to continue daily activities while undergoing treatment. APD takes convenience a step further by utilizing a machine to automate dialysate exchanges at night, allowing patients to receive treatment while they sleep. The demand for CAPD and APD is driven by their ability to provide steady and continuous toxin removal, leading to more stable blood chemistry and improved overall health. These techniques also minimize the need for frequent visits to a dialysis center, reducing the disruption to patients' daily lives. Furthermore, CAPD and APD are well-suited for home-based care, aligning with the growing trend towards personalized healthcare and remote monitoring. Patients can receive training to perform these procedures at home, giving them a sense of empowerment and control over their treatment. As patients and healthcare providers increasingly recognize the benefits of CAPD and APD, the demand for these techniques is expected to rise. This, in turn, is fueling market growth by encouraging further research and innovation in peritoneal dialysis technology, as well as the expansion of training programs and support services for patients opting for these methods.

Dialysis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global dialysis market, along with forecasts at the global, regional, and country levels from 2025-2033. The market has been categorized based on type, product and services, and end user.

Analysis by Type:

• Hemodialysis
  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Hemodialysis stands as the largest component in 2024, accounting to 97.6% of the market share. Hemodialysis, a prominent renal replacement therapy, exerts substantial influence due to its widespread adoption and several associated factors. Its efficacy in rapidly removing toxins, excess fluids, and waste products from the bloodstream addresses crucial medical needs in patients with kidney dysfunction. As a result, its demand is driven by the growing prevalence of chronic kidney diseases, kidney failures, and related conditions. The continuous advancement of hemodialysis technology improved treatment outcomes and patient experiences. Innovations such as high-efficiency dialyzers, vascular access techniques, and online monitoring systems have made hemodialysis more effective, comfortable, and accessible. Moreover, establishing specialized hemodialysis centers and integrating telehealth solutions widened the reach of this treatment, making it accessible to more patients, including those in remote areas. These factors combined contribute to the segment's pivotal role in driving overall market growth as the demand for efficient renal replacement therapies rises.

Analysis by Product and Services:

• Services
• Equipment
  • Dialysis Machines
  • Water Treatment Systems
  • Others
• Consumables
  • Dialyzers
  • Catheters
  • Others
• Dialysis Drugs

Services lead the market in 2024, accounting to 79.0% of the market share. This segment encompasses a range of essential offerings that directly impact patient care, treatment accessibility, and overall industry expansion. Medical service providers, including healthcare professionals and specialized dialysis clinics, contribute significantly to the growth of this segment. These services encompass various aspects of patient care, from initial diagnosis and treatment planning to ongoing monitoring and support. The availability of high-quality medical services is crucial in attracting patients to seek timely interventions for kidney-related issues, which is another factor contributing to the growth of this segment.

Analysis by End User:

• In-center Dialysis
• Home Dialysis

In- center dialysis leads the market in 2024. In-center dialysis refers to treatments conducted within specialized dialysis centers or clinics under the supervision of trained medical professionals. This setting offers various advantages, including access to advanced medical equipment, close monitoring by healthcare staff, and the opportunity for patients to interact with peers facing similar health challenges. The convenience and comprehensive care provided by in-center dialysis centers attract patients who require regular and closely supervised treatments. This includes individuals with advanced kidney diseases, complex medical histories, or those who benefit from personalized care plans. Moreover, in-center dialysis centers often house cutting-edge technology and skilled healthcare teams, ensuring high-quality treatment delivery. Moreover, in-center dialysis provides patients with structured environment, professional support, and regular check-ins. This segment caters to a substantial portion of the patient population, contributing significantly to the demand for dialysis services.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2024, North America accounted for the largest market share of over 41.0%. With its well-established healthcare infrastructure, North America is at the forefront of adopting and implementing innovative dialysis technologies and treatment methodologies. This region's focus on research and development (R&D) fosters continuous advancements in dialysis machines, equipment, and treatment protocols, enhancing the overall quality of patient care. The increasing prevalence of chronic kidney diseases, often associated with lifestyle factors such as obesity and diabetes, drives the demand for dialysis services in North America. A significant aging population also contributes to the rising need for renal replacement therapies. Supportive government initiatives, reimbursement policies, and awareness campaigns further promote early diagnosis and intervention for kidney-related issues, augmenting the utilization of dialysis treatments. Additionally, the concentration of leading dialysis companies and medical research institutions in North America fuels the development and dissemination of state-of-the-art dialysis solutions.

Key Regional Takeaways:
 

United States Dialysis Market Analysis

In 2024, the United States accounted for 87.80% of the North America dialysis market. The increasing focus on the betterment of healthcare systems led to considerable financial inputs aimed at improving access to life-saving treatments. Reports indicate that in 2023, the U.S. spent USD 4.9 Trillion on healthcare, where 60% of the total expenditure was comprised of hospital care, physician and clinical services, and retail prescription drugs. This trend has had significant beneficial effects on the services regarding dialysis. Also, efforts made to increase advanced treatment centers, modernization of machinery, and furthering specialty training for medical professionals have increased in uptake. Policies with an ultimate goal of improved patient-care outcomes have been fast movers in creating innovations specifically intended to suit needs in providing regular renal support to persons. The availability of funding has facilitated the establishment of numerous treatment centers, reduced patient travel time and improving accessibility. Furthermore, initiatives to promote awareness about chronic kidney conditions and their management have encouraged earlier intervention and greater reliance on these life-sustaining therapies. The integration of advanced technology to support better patient monitoring and efficient workflows further propelled adoption rates, making it a critical component of healthcare improvement strategies.

Asia Pacific Dialysis Market Analysis

With the increasing rise of kidney-related illnesses, the trend of adopting dialysis at most health care centers has also emerged. Thereby, notably, the instances of kidney failure, at nearly 210,000 new cases every year, call for an immediate requirement for dialysis adoption-an approach that saves lives by being a lifesaving means for the effective management of chronic conditions. An accelerating awareness of advanced treatment facilities and better access to health care encouraged patients to take dialysis as a necessary solution for chronic illnesses. Moreover, the escalating lifestyle diseases such as hypertension and diabetes have significantly increased the risk of diseases for kidneys, which in turn is creating further demand for dialysis. Furthermore, ongoing technological advancements in equipment and techniques of dialysis are also contributing to an increased acceptance rate as a result of improved comfort along with effectiveness. Urbanization and changes in the existing healthcare infrastructure have made dialysis accessible to larger populations even in areas where awareness remained limited. Additionally, government favorable initiatives and educational campaigns are also assisting in early diagnosis and subsequent timely intervention, thereby highlighting the role of dialysis in prolonging life expectancy and improving patient outcomes. The number of individuals requiring dialysis continues to increase steadily, due to an aging population with a growing burden of chronic diseases.

Europe Dialysis Market Analysis

The increasing number of home-based treatments has improved the care delivery system as it offers more convenience and independence to the patients. For instance, home dialysis in the UK is in rapid increase with more than 25,000 currently undergoing treatment. Hemodialysis cases increased by 10%. Flexibility in their treatment schedules enables people to integrate therapy into their day-to-day activities, improve adherence, and satisfaction. This model reduces dependence on in-clinic visits. Thereby, it reduces the pressure on healthcare infrastructure and will enable providers to focus on resource-intensive cases. Portable equipment, combined with tailored support services has made home-based options accessible and effective. Remote monitoring and virtual consultations have ensured consistent oversight by healthcare professionals, addressing patient concerns promptly. Training programs for patients and caregivers further strengthen the feasibility of administering therapies outside traditional settings. Such developments have reinforced adoption, particularly among those seeking greater control over their healthcare journey. These trends highlight the growing importance of personalized, patient-centric solutions in addressing chronic kidney conditions.

Latin America Dialysis Market Analysis

Expanding private sector involvement increased the adoption of advanced medical treatments by fostering innovation and competition. According to International Trade Administration, Brazil, the largest healthcare market in Latin America, spends 9.47% of its GDP (USD161 Billion) on healthcare, with 62% of its 7,191 hospitals being private. High-quality dialysis services are becoming increasingly accessible due to investments in modern facilities and advanced technologies. Private healthcare providers prioritize efficient service delivery and patient satisfaction, which resulted in streamlined processes and tailored treatment plans. Improved infrastructure supports specialized centers catering to renal conditions, reducing waiting times and improving outcomes. Public-private collaborations have also contributed to improving accessibility for a broader demographic, addressing the rising demand for reliable and effective therapies. This dynamic growth has positioned renal treatments as a key area for ongoing improvement and patient-centered care.

Middle East and Africa Dialysis Market Analysis

Expanding infrastructure has been pivotal in improving access to essential medical services. According to Dubai Healthcare City Authority report, by 2022, Dubai had 4,482 private medical facilities, including 56 hospitals, and 55,208 licensed professionals. With projected growth of 10-15% in medical professionals and 3-6% in facilities, the expanding healthcare sector will improve dialysis care accessibility. Newly developed treatment centers and improved diagnostic capabilities have played a crucial role in addressing the growing prevalence of renal conditions. These developments have ensured that therapies are more widely available, even in remote areas. Investment in workforce development has improved the expertise of medical professionals, ensuring high-quality care delivery. Community outreach programs have raised awareness about chronic kidney conditions and the importance of early intervention, encouraging increased reliance on advanced therapies. The incorporation of innovative solutions to improve treatment efficiency has further propelled the adoption of dialysis as a critical healthcare service.

Competitive Landscape:

The dialysis market is very competitive, with numerous healthcare providers, equipment manufacturers, and service operators. The market is technologically driven, with companies trying to innovate in developing dialysis machines, home dialysis solutions, and integrated care models. High demand for personalized treatment and cost-effective therapies resulted in massive investments in research and development (R&D). Expanding infrastructures of healthcare, government support, and effective reimbursement policies are also accelerating market competition. Providers' differentiation is also done through service quality, patient outcome, and strategic partnerships for expanding market share and to meet the increasing flow of patients.

The report provides a comprehensive analysis of the competitive landscape in the dialysis market with detailed profiles of all major companies, including:

• Asahi Kasei Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• DaVita Inc.
• Fresenius Medical Care AG & Co. KGaA
• JMS Co. Ltd.
• Medtronic plc
• Nikkiso Co. Ltd.
• NIPRO Corporation
• Satellite Healthcare Inc.
• Toray Industries Inc.

Latest News and Developments:

• December 2024: U.S. Renal Care enrolled the first patient in the VOICE clinical trial to evaluate Vafseo® (vadadustat) for chronic kidney disease (CKD) patients on dialysis. Led by Akebia Therapeutics, the trial will compare Vafseo's effectiveness in reducing mortality and hospitalization against standard treatments. This marks a significant step in addressing kidney disease outcomes. The trial's initiation was announced in September 2024.
• December 2024: DCDC Health Services Pvt Ltd secured an investment of approximately USD 9.85 Million from British International Investment (BII) to expand its dialysis clinic network. The funding will support the rollout of over 900 dialysis machines across 100+ centers, targeting over 15,000 low-income patients with End-Stage Renal Disease (ESRD). The expansion is projected to create approximately 1,000 direct jobs within the next 3 years. This initiative aims to deliver critical, life-saving dialysis treatments to underserved communities.
• December 2024: Rockwell Medical signed a multi-year agreement with a global leader in dialysis products, projected to generate over USD 10 Million in net sales for 2025. The partnership includes incremental price increases annually and spans up to five years. Rockwell will supply its hemodialysis products to the customer as part of this collaboration. This deal strengthens Rockwell's position in the global dialysis market.
• April 2024: Royal Victoria Regional Health Centre (RVH) commenced a Home Hemodialysis Program, which provides chronic kidney disease patients with greater flexibility and improved quality of life. The program equips patients to manage dialysis at home, supported by training from specialized nurses like Allie Flewelling. Dr. Murali Krishnan highlights this milestone as pivotal in improving regional care. RVH, Ontario's youngest and fastest-growing renal program, now provides a comprehensive range of treatment options.
• March 2024: Akebia Therapeutics achieved a significant milestone as the FDA approved its Vafseo tablets for treating anemia linked to chronic kidney disease in adults undergoing dialysis. This approval highlights Vafseo’s potential to address an unmet need in managing dialysis-related anemia. The treatment is expected to improve the quality of life for patients with chronic kidney disease. Akebia's success highlights its commitment to advancing innovative therapies in nephrology.

Dialysis Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the dialysis market from 2019-2033.
• The dialysis market research report provides the latest information on the market drivers, challenges, and opportunities in the global market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's Five Forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the dialysis industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.